IPO Ideas
Patel Chem Specialities Limited IPO logo

Patel Chem Specialities Limited IPO

BBSMEBSEListed
Listed at
110
+30.95%

Patel Chem Specialities Limited IPO is a SME book building IPO. Price band is ₹84 per share. Minimum investment is ₹2.69 L. Lot size is 1600 shares. Open from 25 Jul 2025 to 29 Jul 2025. Allotment on 30 Jul 2025. Listing on 1 Aug 2025 at BSE. Managed by Cumulative Capital Private Limited,Unistone Capital Pvt Ltd. Registrar: MUFG Intime India Private Limited (Link Intime). Key details for GMP, subscription, price, allotment, and listing in one place.

Official documents: RHP and DRHP.

Patel Chem Specialities Limited IPO overview

Patel Chem Specialities Limited IPO Key figures

Price band, lot, minimum application, and issue window at a glance.

Price band
₹84
Lot size
1600 shares / lot
Min investment
₹2,68,800
Issue open – close
25 Jul 2025 → 29 Jul 2025

Patel Chem Specialities Limited IPO important dates

Issue Opens
25 Jul 2025
Issue Closes
29 Jul 2025
Allotment
30 Jul 2025
Listing
1 Aug 2025

Patel Chem Specialities Limited IPO lot size

CategoryLotsSharesAmount
Retail (Min)23,2002,68,800
S-HNI (Min)34,8004,03,200
S-HNI (UPI)34,8004,03,200
S-HNI (Max)711,2009,40,800
B-HNI (Min)812,80010,75,200

About Patel Chem Specialities Limited IPO

From the company / RHP narrative.

Incorporated in 2008, Patel Chem Specialities Limited (PCSL) is engaged in the manufacturing and exporting pharmaceutical excipients and specialty chemicals.

The company manufactures various essential chemicals used in pharmaceuticals, food, cosmetics, and industrial applications, serving as binders, disintegrants, thickeners, stabilizers, and gelling agents across industries.

The company’s manufacturing facilities in Vatva, Ahmedabad, and Talod, Himmatnagar, follow strict quality control standards, ensuring bulk production of chemicals that meet international certifications like US-DMF and GMP.


The company’s manufacturing facility covers 7,000 square yards, with a capacity of over 7,200 MT annually for pharmaceutical excipients, featuring departments for storage, production, R&D, quality control, packaging, and warehousing.

The company has expanded globally, serving East Asia, Europe, the Middle East, North America, and Southeast Asia, delivering high-quality products that meet international standards to lead the chemical industry.

Product Portfolio:

Rheollose® (Sodium Carboxymethyl Cellulose): A cellulose gum used as a thickening and stabilizing agent in various applications.
Disolwell® (Croscarmellose Sodium): A super disintegrant used in oral pharmaceutical formulations to enhance tablet disintegration.
Swellcal® (Calcium Carboxymethyl Cellulose): Used as a super disintegrant in pharmaceutical applications.
AmyloTab™ (Pregelatinized Starch): Used in tablet formulations to aid in the disintegration and dissolution processes.

As of March 31, 2025, the company has a total strength of 136 employees.

Objective of the issue

How the issuer plans to use IPO proceeds.

Funding capital expenditure requirement of the Company

General corporate purposes
Patel Chem Specialities Limited IPO FAQs
A quick overview of key terms, dates, and how to track this IPO.

Documents & links

Prospectus, draft filings, and company site open in a new tab.

Registrar

Details about the registrar of the issue.

Registrar Name
MUFG Intime India Private Limited (Link Intime)
Phone
2249186270
Address
Link Intime India Private Ltd C 101, 247 Park, L.B.S.Marg, Vikhroli (West), Mumbai - 400083

Issue details

Key details about the issue, including the face value, lot size, and minimum investment.

Issue Type
BB
Face Value
10
Lead Managers
Cumulative Capital Private Limited,Unistone Capital Pvt Ltd
Min Quantity
3,200
Company Promoters
Bhupesh Patel,Anshu Patel,,Vini Patel
Phone
91- 9712999854
Address
Patel Chem Specialities Ltd. Plot No. 272/4-5, Phase II, G.I.D.C Industrial Estate, Vatva Road Ahmedabad, Gujarat, 382445

Related articles

Research posts and updates that reference this company or theme.

Follow IPO & unlisted research in the app, available on iOS and Android.